Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions
Year: 2022
Type: article
Abstract: Brain metastases occur commonly in patients with advanced solid malignancies. Yet, less is known about brain metastases than cancer-related entities of similar incidence. Advances in oncologic care have heightened the importance of intracranial management. Here, in this consensus review supported by the Society for Neuro-Oncology (SNO), we review the landscape of brain metastases with particular attention to management approaches and ongoing efforts with potential to shape future paradigms of care. Each coauthor carried an area of expertise within the field of brain metastases and initially composed, edited, or reviewed their specific subsection of interest. After each subsection was accordingly written, multiple drafts of the manuscript were circulated to the entire list of authors for group discussion and feedback. The hope is that the these consensus guidelines will accelerate progress in the understanding and management of patients with brain metastases, and highlight key areas in need of further exploration that will lead to dedicated trials and other research investigations designed to advance the field.
Source: Neuro-Oncology
Authors: Ayal A Aizer, Nayan Lamba, Manmeet S Ahluwalia, Kenneth Aldape, Adrienne Boire, Priscilla K Brastianos, Paul D Brown, D Ross Camidge, Veronica L Chiang, Michael A Davies, Leland S Hu, Raymond Y Huang, Timothy Kaufmann, Priya Kumthekar, Keng Lam, Eudocia Q Lee, Nancy U Lin, Minesh Mehta, Michael Parsons, David A Reardon, Jason Sheehan, Riccardo Soffietti, Hussein Tawbi, Michael Weller, Patrick Y Wen
Institutions: Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Harvard University, National Institutes of Health, National Cancer Institute, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, Mayo Clinic, Yale University, The University of Texas MD Anderson Cancer Center, Mayo Clinic Hospital, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Kaiser Permanente, Los Angeles Medical Center, University of Virginia, University of Turin, University of Zurich, University Hospital Zurich
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: American Cancer Society, AstraZeneca, Bayer, Merck, Novartis, Melanoma Research Alliance, Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, AbbVie, Varian Medical Systems, AIM at Melanoma, Novocure, Agios Pharmaceuticals, Incyte, Arizona Biomedical Research Commission, National Institutes of Health, Pharmacyclics, National Cancer Institute, National Center for Advancing Translational Sciences
OpenAlex ID: W4283688930